The deal range was $3.35-$3.70. Morgan Stanley, Goldman Sachs, BofA and TD Cowen acted as joint book running managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SANA:
- Sana Biotechnology Reports Non-Cash Impairment Losses
- Sana Biotechnology announces $75M common stock offering
- Promising Developments and FDA Engagement Bolster Buy Rating for Sana Biotechnology
- Sana Biotechnology announces publication on clinical data from transplantation
- Positive Outlook on Sana Biotechnology Driven by Promising T1D Program and Allogeneic CAR-T Advancements